Global Utilities

Hulett Laboratory

Department of Biochemistry

Publications

(* co-corresponding and equal senior author)

Lay, F.T., Mills, G.D., HULETT*, M.D. and Kvansakul, M*. 2011 Crystallization and preliminary X-ray crystallographic analysis of the plant defensin NaD1. Acta Crystallogr Sect F Struct Biol Cryst Commun. 68: 85-88.

Poon, I.K., Patel, K.K., Davis, D.S., Parish*, C.R. and HULETT*, M.D. 2011. Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood. 117:2093-101.

Poon, I.K.A., HULETT*, M.D. and Parish*. C.R. 2010. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ. 17: 381-97.

Poon, I.K.H, HULETT*, M.D. and Parish*, C.R. 2010. Histidine-rich glycoprotein is a novel plasma pattern recognition molecule that recruits IgG to facilitate necrotic cell clearance via FcRI on phagocytyes. Blood. 115: 2473-82.

Poon IK, Parish* CR, and HULETT*, M.D. 2010. Histidine-rich glycoprotein functions cooperatively with cell surface heparan sulfate on phagocytes to promote necrotic cell uptake. J Leukoc Biol. 88: 559-69.

Poon IK, Yee DY, Jones AL, Wood RJ, Davis DS, Freeman C, Parish* CR and HULETT*, M.D. 2010. Histidine-rich glycoprotein binds heparanase and regulates its enzymatic activity and cell surface interactions. Int J Biochem Cell Biol. 42:1507-16.

Poon, I.K.H, Olsoon, A.K., HULETT*, M.D. and Parish*, C.R. 2009. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage. J. Biochem. 424: 27-37.

Kavallaris, M., Meachem, S.J., HULETT, M.D., West, C.M., Pitt, R.E., Chesters, J.J., Laffan, W.S., Boreham, P.R., Khachigian, L.M. 2008 Perceptions in health and medical research careers: the Australian Society for Medical Research Workforce Survey. Med J Aust. 188:520-524.

Quah, B., Barlow, V.P., McPhun, V., Matthaei, K.I., HULETT, M.D. and Parish, C.R. 2008. Bystander B Cells Rapidly Acquire Antigen Receptors from Activated B Cells by Membrane Transfer: a Novel Mechanism for Enhancing Specific Antigen Presentation. Proc. Natl Acad. Sci. U. S. A. 2008 105:4259-4264.

Wood, R. and HULETT M.D. 2007. Cell surface expressed cation-independent mannose-6 phosphate receptor (CD222) binds enzymatically active heparanase independently of mannose-6 phosphate to promote extracellular matrix degradation. J. Biol. Chem. 283:4165-4176

de Mestre, A.M., Staykova, M., Hornby, J., Willenborg, D. and HULETT M.D. 2007. The expression of the heparan sulphate degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1 . J. Leuk. Biol. 82:1289-300.

de Mestre, A.M., Soe-Htwe, T., Sutcliffe, E.L., Rao, S., Pagler, E.B., Hornby, J.R. and HULETT, M.D. 2007. Regulation of mouse Heparanase gene expression in T lymphocytes and tumour cells. Immunol. Cell Biol. 85:205-214.

Forbes, E., HULETT, M.D., Ahens, R., Smart, V., Matthaei, K.I., Brandt, E., Rothenberg, M.E., Tang, M., Foster, P.S. and Hogan, S.P. 2006. ICAM-1 dependent pathways regulate colonic eosinophilic inflammation. J. Leuk. Biol. 80:330-41.

Abby, J.L., HULETT M.D. and O’Neill H. 2006. Cell surface expression of a peptide encoded by the un-rearranged TCR-Vbeta 8.2 gene. Mol. Immunol. 43:1408-1417.

Jones, A.L., Poon, I., HULETT, M.D. and Parish, C. R. 2005. Histidine-rich glycoprotein specifically binds to necrotic cells, via its amino-terminal domain, and facilitates necrotic cell phagocytosis. J. Biol. Chem. 280:35733-35741.

Jones, A.L., HULETT, M.D. and Parish, C. R. 2005. Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol. 83:106-18.

de Mestre, A.M, Rao, S., Hornby, J.R., Soe Htwe, Khachigian, L.M. and HULETT M.D. 2005. EGR1 regulates heparanase gene transcription in tumour cells. J. Biol. Chem. 280:35136-35147.

Jones, A.L., HULETT, M.D., Altin, J.G., Hogg, P. and Parish C.R. 2004. Plasminogen is tethered with high affinity to the cell surface by the plasma protein, histidine-rich glycoprotein. J Biol. Chem. 279: 38267-38276.

Jones, A.L., HULETT, M.D. and Parish C.R. 2004. Histidine-rich glycoprotein binds to cell surface heparan sulfate via its amino-terminal domain following Zn2+ chelation. J. Biol. Chem. 279:30114-30122.

de Mestre, A.M., Khachigian L.M., Santiago, F.S., Staykova, M.A. and HULETT M.D. 2003. Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1. J. Biol. Chem. 278:50377-50385.

Mattes, J., HULETT, M.D., Xie, W., Hogan, S., Rothenberg, M.E., Foster, P. and Parish C.R. 2003. Immunotherapy of cytotoxic T cell resistant tumors by T helper 2 cells: an eotaxin and STAT6 dependent process. J. Exp. Med. 197: 387-393.

Mackay, G.A., HULETT, M.D., Cook, J.P.D., Trist, H.M., Henry, A.J., Beavil, A.J., Beavil, R.L., Sutton, B.J., Hogarth, P.M. and Gould H.J. 2002. Mutagenesis within human FcRI differentially affects human and murine IgE. J. Immunol., 168, 1787-1795.

Parish, C. R., C. Freeman and M.D. HULETT. 2001. Heparanase: a key enzyme involved in cell invasion. Biochimica et Biophysica Acta - Reviews in Cancer 1471: M99-M108.

HULETT, M.D., Pagler, E. and Hornby J.R. 2001. Cloning and characterisation of a mouse homologue of the human hematopoietic cell-specific four-transmembrane gene HTm4. Immunol Cell Biol., 79, 345-349.

HULETT, M.D., E. Pagler, J. Hornby, P.M. Hogarth, H.J. Eyre, E. Baker, J. Crawford, G.R. Sutherland and Parish, C.R. 2001. Isolation, tissue distribution, and chromosomal localisation of a novel testis-specific human four-transmembrane gene related to CD20 and FcRI. Biochem. Biophys. Res. Commun., 280, 374-379.

HULETT, M.D., J. Hornby, S. Ohms, J. Zeugg, C. Freeman, J. Greedy and C.R. Parish. 2000. Identification of active site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry, 39, 15659-15667.

Rigby, L.J., H. Trist, H., V.C. Epa, J. Snider, M.D. HULETT and P.M. Hogarth. 2000. Monoclonal antibodies and synthetic peptides define the active site of FcRI and a potential receptor antagonist. Allergy, 55, 609-619.

Rigby, L.J., V.C. Epa, G.A. Mackay, M.D. HULETT, B.J. Sutton, H.J. Gould and P.M. Hogarth. 2000. Domain one of the high affinity Fc epsilon receptor, FcRI, regulates binding to IgE through its interface with domain two. J. Biol. Chem., 275, 9664-9672.

HULETT, M.D. and C.R. Parish. 2000. Murine Histidine-rich Glycoprotein: Cloning, characterisation and cellular origin. Immunol. Cell Biol., 78, 280-287.

Baker, E., J. Crawford, G.R. Sutherland, C. Freeman, C.R. Parish, and M.D. HULETT. 1999. Human Hpa. Endogylcosidase heparanase. Map postion 4q21.3. Chromosome Research 7, 319.

HULETT, M.D., C. Freeman, B.J. Hamdorf, R.T. Baker, M.J. Harris, and C.R. Parish. 1999. Cloning of mammalian heparanase: A key enzyme in tumour invasion and metastasis. Nature Medicine 5:803-809.

Maxwell, K.F., M.S. Powell, M.D. HULETT, P.A. Barton, I.F.C. McKenzie, T.P. Garrett and P.M. Hogarth. 1999. Crystal structure of the human leukocyte Fc receptor FcRIIa. Nature Structural Biology 6:437-442.

HULETT, M.D. E. Witort, R. Brinkworth, I.F.C. McKenzie and P.M. Hogarth. 1999. Fine structure analysis of the interaction of FcRI with IgE. J. Biol. Chem. 274:13345-13352.

Wines, B. D., M.D. HULETT, G.P. Jamieson, H.M. Trist, J.M. Spratt, and P.M. Hogarth. 1999. Identification of residues in the first domain of Human FcR essential for interaction with IgA. J. Immunol. 162:2146-2153.

For other publications by this author:

This will open a new browser window and connect you in to the NCBI PubMed database. Please close the new window to come back to this page.

 

Content Approved by: Head of Department
Page maintained by: Web Administrator
Last Updated: 17 January, 2012